Zobrazeno 1 - 10
of 2 341
pro vyhledávání: '"Fangusaro, J"'
Autor:
Power P; Department of Pediatric Oncology, Dana-Farber/ Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Cambridge, MA, USA., Straehla JP; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA., Fangusaro J; Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA; Aflac Cancer Center, Atlanta, GA, USA., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber/ Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Manoharan N; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia. Electronic address: neevika.manoharan@health.nsw.gov.au.
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2025 Jan; Vol. 59, pp. 101098. Date of Electronic Publication: 2024 Dec 04.
Autor:
Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada., Bennett J; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Ostrom Q; The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina, USA.; Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA., Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuro-oncologie, Paris, France.; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Franceschi E; Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna / AUSL di Bologna, Bologna, Italy., Schulte J; Neurosciences Department, University of California San Diego, La Jolla, California, USA., Bindra RS; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA., Fangusaro J; Children's Healthcare of Atlanta, Emory University, and the Aflac Cancer Center, Atlanta, Georgia, USA., Dhall G; Department of Hematology and Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA., Nicholson J; Paediatric Oncology, Cambridge University Hospitals and Department of Paediatrics, Cambridge University, UK., Jackson S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA., Davidson TB; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Calaminus G; Paediatric Haematology and Oncology, University Hospital Bonn, Bonn, Germany., Robinson G; Department of Oncology, Neurobiology and Brain Tumor Program, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Personalised Oncology Division, WEHI, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia., Hau P; Department of Neurology and Wilhelm Sander-Neuro-Oncology Unit, Regensburg University Hospital, Regensburg, Germany., Ramaswamy V; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Heidelberg, Germany., Rudà R; Division of Neuro-Oncology, Department Neuroscience Rita Levi Montalcini, University of Turin and City of Health and Science University Hospital, Turin, Italy., Foreman NK; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA., Hervey-Jumper SL; Department of Neurological Surgery, University of California, San Francisco, California, USA., Das S; Division of Neurosurgery, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Dirks P; Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Huang A; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Merchant TE; Department of Radiation Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA., Fouladi M; Division of Hematology/Oncology, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA., Van den Bent MJ; The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Packer RJ; Brain Tumor Institute, Gilbert Family Neurofibromatosis Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, District of Columbia, USA., Miller JJ; Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Reardon DA; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Chang SM; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, California, USA., Haas-Kogan D; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA., Tabori U; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Hawkins C; Department of Pathology, The Hospital for Sick Children, Toronto, Ontario, Canada., Monje M; Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.; Howard Hughes Medical Institute, Stanford University, Stanford, California, USA., Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Bouffet E; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Yeo KK; Department of Pediatric Oncology, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Oct 23. Date of Electronic Publication: 2024 Oct 23.
Autor:
O'Hare P; Department of Paediatric Oncology, Royal Belfast Hospital for Sick Children, Northern Ireland, UK., Cooney T; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA.; Day One Biopharmaceuticals, Boston, Massachusetts, USA., de Blank P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA.; University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Kieran M; Day One Biopharmaceuticals, Boston, Massachusetts, USA., Milde T; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Fangusaro J; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA., Fisher M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Avula S; Department of Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK., Packer R; Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, District of Columbia, USA., Fukuoka K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Mankad K; Department of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, Department of Radiology, London, UK., Mueller S; Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, California, USA., Waanders AJ; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Opocher E; Paediatric Haematology, Oncology and Stem Cell Transplant Division, Padua University Hospital, Padua, Italy., Bouffet E; The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Raabe E; Division of Pediatric Oncology, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Werle NE; Pediatric Onco-Hematology Department, University Hospital of Strasbourg. UMR CNRS 7021, University of Strasbourg, Strasbourg, France., Azizi AA; Department of Pediatrics and Adolescent Medicine and Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria., Robison NJ; Division of Hematology & Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA., Hernáiz Driever P; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German HIT-LOGGIC-Registry for LGG in children and adolescents, Department of Pediatric Oncology/Hematology, Berlin, Germany., Russo M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Schouten N; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., van Tilburg CM; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Sehested A; Department of Paediatrics and Adolescent Medicine, The University Hospital Rigshospitalet, Copenhagen, Denmark., Grill J; Department of Pediatric and Adolescent Oncology, Villejuif, France., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA., Kilday JP; The Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer Sciences, University of Manchester, and Royal Manchester Children's Hospital, Manchester, UK., Witt O; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Ashley DM; Department of Neurosurgery, The Preston Robert Tisch Brain Tumor Center. Pediatric Neuro-Oncology, Preuss Laboratory for Brain Tumor Research, Durham, North Carolina, USA., Ertl-Wagner BB; Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada., Tabori U; The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Hargrave DR; UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital for Children, London, UK.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Aug 05; Vol. 26 (8), pp. 1357-1366.
Autor:
Fangusaro J; Children's Hospital of Atlanta, Emory University and the Aflac Cancer Center, Atlanta, Georgia., Avery RA; The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Fisher MJ; The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Packer RJ; Center for Neuroscience and Behavioral Medicine and Brain Tumor Institute, Children's National Hospital, and The George Washington University School of Medicine, Washington, DC., Walsh KS; Center for Neuroscience and Behavioral Medicine and Brain Tumor Institute, Children's National Hospital, and The George Washington University School of Medicine, Washington, DC., Schouten-van Meeteren A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Karres D; Pediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, the Netherlands., Bradford D; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland., Bhatnagar V; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland., Singh H; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland., Donoghue M; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland., Duke ES; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2303-2308.
Autor:
Mueller S; Department of Neurology, Neurological Surgery and Pediatrics, University of California, San Francisco, San Francisco, California, USA.; Department of Pediatrics, University Children's Hospital, University of Zurich, Zürich, Switzerland., Fangusaro J; Department of Hematology and Oncology, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA., Thomas AO; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee, USA., Jacques TS; UCL Great Ormond Street Institute of Child Health and Histopathology Department, Developmental Biology and Cancer Programme, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., de Blank P; Department of Pediatrics, University of Cincinnati Medical Center and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Packer RJ; Brain Tumor Institute, Washington DC, USA.; Gilbert Family Neurofibromatosis Institute, Washington DC, USA.; Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, District of Columbia, USA., Fouladi M; Pediatric Brain Tumor Program, Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio, USA., van Meeteren AS; Princess Màxima Center for Pediatric Oncology, Department of Neuro-oncology, Utrecht, The Netherlands., Jones D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany., Perry A; Departments of Pathology and Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Nakano Y; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada., Hargrave D; Department of Paediatric Oncology, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK., Riedl D; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.; Ludwig Boltzmann Institute for Rehabilitation Research, Vienna, Austria., Robison NJ; Division of Hematology and Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA.; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Partanen M; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Fisher MJ; Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Witt O; Hopp Children's Cancer Center (KiTZ), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and University Hospital, Heidelberg, Germany.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Mar 04; Vol. 26 (3), pp. 407-416.
Autor:
Fangusaro J; Department of Hematology and Oncology, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA., Jones DT; Translational Program, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; German Cancer Research Center (DKFZ), University Hospital Heidelberg, Heidelberg, Germany., Packer RJ; Brain Tumor Institute, Daniel and Jennifer Gilbert Neurofibromatosis Institute, Neuroscience and Behavioral Medicine, Children's National Medical Center, Washington, District of Columbia, USA., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Milde T; Translational Program, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; German Cancer Research Center (DKFZ), University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Witt O; Translational Program, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; German Cancer Research Center (DKFZ), University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Mueller S; Department of Neurological Surgery, University of California, San Francisco, California, USA.; Department of Pediatrics, University of California, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, California, USA.; Department of Oncology, University Children's Hospital Zürich, Zürich, Switzerland., Fisher MJ; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Hansford JR; Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.; South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia., Tabori U; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Hargrave D; University College London Great Ormond Street Institute of Child Health, London, UK., Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Jan 05; Vol. 26 (1), pp. 25-37.
Autor:
Monje M; Department of Neurology, Stanford University and Lucile Packard Children's Hospital, Palo Alto, CA, USA., Cooney T; Department of Pediatric Oncology, Dana Farber Cancer Institute/Boston Children's Hospital, Boston, MA, USA., Glod J; Pediatric Oncology, Pediatric Oncology Branch, National Cancer Institute, Bethesda, MDUS., Huang J; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Peer CJ; Center for Cancer Research, Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Faury D; Research Institute of the McGill University Health Center, Montreal, QuebecCANADA., Baxter P; Pediatric Oncology, Texas Children's Cancer Center, Houston, TX, USA., Kramer K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA., Lenzen A; Pediatric Hematology Oncology, Lurie Children's Hospital, Chicago, IL, USA., Robison NJ; Department of Pediatrics, Children's Hospital, Los Angeles, CA, USA., Kilburn L; Department of Oncology, Children's National Hospital, Washington, DC, USA., Vinitsky A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Figg WD; Center for Cancer Research, Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Jabado N; Research Institute of the McGill University Health Center, Montreal, QuebecCANADA., Fouladi M; Pediatric Hematology Oncology, Nationwide Children's Hospital, Columbus, OH, USA., Fangusaro J; Department: Pediatric Hematology/Oncology and Stem Cell Transplantation, Atlanta, GA, USA., Onar-Thomas A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA., Warren KE; Department of Pediatric Oncology, Dana Farber Cancer Institute/Boston Children's Hospital, Boston, MA, USA.; Pediatric Oncology, Pediatric Oncology Branch, National Cancer Institute, Bethesda, MDUS.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2023 Dec 08; Vol. 25 (12), pp. 2262-2272.
Autor:
Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Fangusaro J; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Fisher MJ; Division of Oncology, Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Hawkins C; Department of Laboratory Medicine and Pathobiology, Hospital for Sick Children, Toronto, Canada., Rodriguez FJ; Department of Pathology, University of California Los Angeles, Los Angeles, California, USA., Tabori U; Department of Medical Biophysics, Institute of Medical Science and Paediatrics, University of Toronto, Toronto, Canada., Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Zhu Y; Gilbert Family Neurofibromatosis Institute Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2023 Nov 02; Vol. 25 (11), pp. 1920-1931.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leary SES; Ben Towne Center for Childhood Cancer Research, Seattle Children's Hospital, Seattle, Washington, USA., Onar-Thomas A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Fangusaro J; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA., Gottardo NG; Telethon Kids Cancer Centre, University of Western Australia, Perth, Western Australia, Australia., Cohen K; The Sidney Kimmel Comprehensive Cancer Center, John's Hopkins, Baltimore, Maryland, USA., Smith A; Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, Orlando Health-Arnold Palmer Hospital, Orlando, Florida, USA., Huang A; Department of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada., Haas-Kogan D; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Fouladi M; Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Sep; Vol. 70 Suppl 6, pp. e30600. Date of Electronic Publication: 2023 Aug 03.